Published in Br J Pharmacol on December 01, 2013
TRP channels in the skin. Br J Pharmacol (2014) 0.79
Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels. Br J Pharmacol (2014) 0.77
The background to this themed issue on neuropeptides. Br J Pharmacol (2013) 0.75
Extraoral Taste Receptor Discovery: New Light on Ayurvedic Pharmacology. Evid Based Complement Alternat Med (2017) 0.75
Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients. Int J Mol Sci (2017) 0.75
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron (1998) 13.03
Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol (2011) 10.40
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 10.05
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 7.66
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 6.26
An unidentified depressor substance in certain tissue extracts. J Physiol (1931) 5.19
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A (2000) 4.53
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science (1991) 4.06
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol (2000) 3.57
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J (2005) 3.23
TRP channels: an overview. Cell Calcium (2005) 2.98
Primary afferent tachykinins are required to experience moderate to intense pain. Nature (1998) 2.97
Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science (1988) 2.96
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A (2000) 2.87
Sepsis: definition, epidemiology, and diagnosis. BMJ (2007) 2.43
Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci (2004) 2.42
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
The role of substance P in inflammatory disease. J Cell Physiol (2004) 2.19
Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem (2004) 2.17
Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab (2010) 2.11
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther (2004) 2.08
Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock (1996) 2.08
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J (1998) 1.89
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors. Am J Physiol Heart Circ Physiol (2004) 1.88
Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther (1997) 1.74
The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol (2012) 1.69
Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory. Cell Cycle (2012) 1.65
Tachykinins and tachykinin receptors: a growing family. Life Sci (2004) 1.63
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther (2003) 1.62
Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron (2008) 1.61
Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci (2008) 1.60
Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! Pharmacol Ther (2009) 1.56
Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol (1998) 1.54
Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J Dent Res (2006) 1.54
Human lymphocytes express substance P and its receptor. J Neuroimmunol (1998) 1.52
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology (2004) 1.48
Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J Neurosci (2008) 1.48
LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J Dent Res (2011) 1.48
The effects of tachykinins on inflammatory and immune cells. Regul Pept (1997) 1.47
Hydrogen sulfide (H2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br J Pharmacol (2004) 1.46
Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J Biol Chem (2004) 1.44
Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol (1998) 1.43
Localization of the PIP2 sensor of TRPV1 ion channels. J Biol Chem (2011) 1.38
Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol (2006) 1.37
Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol (2005) 1.34
The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther (2009) 1.33
Functional analysis of capsaicin receptor (vanilloid receptor subtype 1) multimerization and agonist responsiveness using a dominant negative mutation. J Neurosci (2001) 1.32
Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A (1998) 1.31
Substance P: a pioneer amongst neuropeptides. J Intern Med (2001) 1.28
The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides (1997) 1.27
Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse. Am J Physiol Gastrointest Liver Physiol (2004) 1.26
Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain (2009) 1.24
Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res (2004) 1.24
Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol (2006) 1.24
Modulation of temperature-sensitive TRP channels. Semin Cell Dev Biol (2006) 1.24
Neurogenic mechanisms in bronchial inflammatory diseases. Allergy (2004) 1.22
Sensory effects of capsaicin congeners I. Relationship between chemical structure and pain-producing potency of pungent agents. Arzneimittelforschung (1975) 1.22
Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J Infect (2003) 1.21
Therapeutic implications of microglia activation by lipopolysaccharide and reactive oxygen species generation in septic shock and central nervous system pathologies: a review. Medicina (B Aires) (1998) 1.20
Role of TRPV receptors in respiratory diseases. Biochim Biophys Acta (2007) 1.19
Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB. Am J Physiol Lung Cell Mol Physiol (2007) 1.19
Cold-seeking behavior as a thermoregulatory strategy in systemic inflammation. Eur J Neurosci (2006) 1.19
Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis (2012) 1.16
Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Mol Pharmacol (2008) 1.15
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J (2007) 1.14
Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br J Pharmacol (2003) 1.12
Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med (2004) 1.12
Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol (2009) 1.09
Distribution of substance P in the central and peripheral nervous system. Nature (1953) 1.08
Advances in understanding sepsis. Eur J Anaesthesiol Suppl (2008) 1.07
Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol (2010) 1.07
Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol (2004) 1.05
A role for substance P in arthritis? Neurosci Lett (2004) 1.05
Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc Res (2011) 1.04
Aprepitant--a novel NK1-receptor antagonist. Expert Opin Pharmacother (2003) 1.04
Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol (2010) 1.04
Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin. Mol Pain (2007) 1.03
Attenuated fever response in mice lacking TRPV1. Neurosci Lett (2004) 1.03
Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience (2000) 1.03
Efferent functions of C-fiber nociceptors. Z Rheumatol (1998) 1.03
Substance P expression in TRPV1 and trkA-positive dorsal root ganglion neurons innervating the mouse lung. Respir Physiol Neurobiol (2004) 1.01
Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab (2011) 1.01
Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol (2003) 1.00
TRP channels and analgesia. Life Sci (2012) 0.99
Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-κB signaling. PLoS One (2011) 0.99
Distribution of transient receptor potential vanilloid 1 channel-expressing nerve fibers in mouse rectal and colonic enteric nervous system: relationship to peptidergic and nitrergic neurons. Neuroscience (2010) 0.98
TRPV1: a stress response protein in the central nervous system. Am J Neurodegener Dis (2012) 0.98
Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension (2008) 0.97
Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J Immunol (2007) 0.97
Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J Immunol (2006) 0.96
Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. J Neurochem (2005) 0.95
TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome. J Immunol (2012) 0.95